NVIV News and Press, InVivo Therapeutics Holdings Corp. From 07/13/21

The FDA has accepted InVivo Therapeutics' ([[NVIV]] +15.2%) preclinical module, one of three individual modules required for the company’s humanitarian device exemption ((HDE)) application.FDA acceptance indicates that the Agency has completed its review and has no outstanding question...

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced the acceptance by the U.S. Food and Drug Administration (FDA) of its preclinical module, which i...

Calls for All Stockholders to Vote and to Vote in Favor of the Proxy Proposals InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today reminded stockh...

Understanding Penny Stocks in 2021 And How to Use Trends to Your Advantage With penny stocks, staying ahead of the competition is one of the most important steps to being a profitable trader. The first step in this process is thinking outside of the box. For example, if you’re tr...

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcom...

5 Biotech Penny Stocks Trending This Week In the past twelve months, biotech penny stocks have become all the rage. Regardless of whether they are working on a covid treatment, investors have shown a massive propensity for penny stocks in the biotechnology industry. The term biotech...

InVivo Therapeutics ([[NVIV]] +5.4%) is trading higher today in above-average volume after the company announced the publication of a peer-reviewed manuscript describing the complete six-month primary endpoint results from its single-arm INSPIRE 1.0 study.The publication in the Jour...

Manuscript Details Complete Six-Month INSPIRE 1.0 Primary Endpoint Study Results InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the recent publication of a peer-reviewed manuscript in the Journal of Neurosurgery: Spine describing the previously pre...

These Penny Stocks May Be To Active To Ignore We’re at the start of a new week, and you better believe research is already getting done on which penny stocks to buy on Tuesday. Whether you use technical analysis, search for fundamentals, or your own “secret sauce, ...

Can These 4 Penny Stocks Continue to Make Headway? So far, February has been kind to a variety of penny stocks . While this month has been quite volatile for the entire stock market, the sentiment seems to be quite bullish overall. Right now, several pieces of news could impact the ...